To date, the studies that cited APOE’s participation in the COVID-19 manifestations have focused on clinical manifestations, and few studies are showing the role of APOE polymorphism in the genesis of post-COVID-19 cognitive manifestations [5,6]. This evidence concerns the gene APOE and COVID-19.